322 related articles for article (PubMed ID: 30276966)
61. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
62. Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma.
Fan T; Zhu M; Wang L; Liu Y; Tian H; Zheng Y; Tan F; Sun N; Li C; He J
Aging (Albany NY); 2020 Dec; 13(2):2397-2417. PubMed ID: 33318300
[TBL] [Abstract][Full Text] [Related]
63. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
[TBL] [Abstract][Full Text] [Related]
64. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
[TBL] [Abstract][Full Text] [Related]
65. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
Xu S; Liu R; Da Y
Thorac Cancer; 2018 Aug; 9(8):974-988. PubMed ID: 29870138
[TBL] [Abstract][Full Text] [Related]
66. Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
Wang X; Shi D; Zhao D; Hu D
Biomed Res Int; 2020; 2020():1807089. PubMed ID: 33029490
[TBL] [Abstract][Full Text] [Related]
67. Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma.
Kadonaga T; Sakabe T; Kidokoro Y; Haruki T; Nosaka K; Nakamura H; Umekita Y
Virchows Arch; 2022 Apr; 480(4):831-841. PubMed ID: 35067776
[TBL] [Abstract][Full Text] [Related]
68. Bioinformatic analysis of microRNA-mRNA expression profiles of bladder tissue induced by bladder outlet obstruction in a rat model.
Duan LJ; Cao QF; Xu D; Liu HL; Qi J
Mol Med Rep; 2017 Oct; 16(4):4803-4810. PubMed ID: 28791388
[TBL] [Abstract][Full Text] [Related]
69. Integrated analysis of genome‑wide gene expression and DNA methylation microarray of diffuse large B‑cell lymphoma with TET mutations.
Liu P; Jiang W; Zhao J; Zhang H
Mol Med Rep; 2017 Oct; 16(4):3777-3782. PubMed ID: 28731140
[TBL] [Abstract][Full Text] [Related]
70. Identification of prognostic genes through expression differentiation during metastatic process in lung adenocarcinoma.
An N; Yang X
Sci Rep; 2017 Sep; 7(1):11119. PubMed ID: 28894185
[TBL] [Abstract][Full Text] [Related]
71. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
72. Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.
Liu Y; Nan F; Lu K; Wang Y; Liu Y; Wei S; Wu R; Wang Y
Cancer Biomark; 2017 Dec; 21(1):11-21. PubMed ID: 29060924
[TBL] [Abstract][Full Text] [Related]
73. Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma.
Wang P; Xu G; Gao E; Xu Y; Liang L; Jiang G; Duan L
Oxid Med Cell Longev; 2022; 2022():8802303. PubMed ID: 35814273
[TBL] [Abstract][Full Text] [Related]
74. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
75. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
76. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
Yerukala Sathipati S; Ho SY
Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
[TBL] [Abstract][Full Text] [Related]
77. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
78. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
79. Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma.
Li Y; He CL; Li WX; Zhang RX; Duan Y
PLoS One; 2020; 15(4):e0230796. PubMed ID: 32236130
[TBL] [Abstract][Full Text] [Related]
80. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.
Shen J; Zhu B
Mol Med Rep; 2018 Jun; 17(6):7636-7644. PubMed ID: 29620215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
